Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results

BJU International

Volumn 111, Issue 6, 2013, Pages 997-1005

  Karam, Jose A ^a   Ahrar, Kamran ^b   Vikram, Raghunandan ^a   Romero, Claudio A ^a   Jonasch, Eric ^a   Tannir, Nizar M ^a   Rao, Priya ^a   Wood, Christopher G ^a   Matin, Surena F ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cryoablation; CT; follow up; kidney cancer; MRI; radiofrequency ablation; renal ablation; renal biopsy; renal cell carcinoma; survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KIDNEY BIOPSY; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETREATMENT; SALVAGE THERAPY; SOLITARY KIDNEY; TERTIARY HEALTH CARE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84876904053     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11608.x     Document Type: Article

References (23)

1. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182: 1271-1279
2. Altunrende F, Autorino R, Hillyer S, et al. Image guided percutaneous probe ablation for renal tumors in 65 solitary kidneys: functional and oncological outcomes. J Urol 2011; 186: 35-41
3. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA,. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 2010; 116: 3135-3142
4. Raman JD, Raj GV, Lucas SM, et al. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int 2010; 105: 496-500
5. Aron M, Kamoi K, Remer E, Berger A, Desai M, Gill I,. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol 2010; 183: 889-895
6. Raman JD, Hall DW, Cadeddu JA,. Renal ablative therapy: radiofrequency ablation and cryoablation. J Surg Oncol 2009; 100: 639-644
7. Levinson AW, Su LM, Agarwal D, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008; 180: 499-504
8. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE,. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007; 189: 429-436
9. Karam JA, Ahrar K, Wood CG, et al. Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma. J Urol 2010; 184: 1882-1887
10. Kutikov A, Uzzo RG,. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009; 182: 844-853
11. Booth J, Matin SF, Ahrar K, Tamboli P, Wood CG,. Contemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques. Urol Oncol 2008; 26: 37-42
12. Ahrar K, Matin S, Wood CG, et al. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol 2005; 16: 679-688
13. Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 2006; 176: 1973-1977
14. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
15. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR,. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185: 64-71
16. Weight CJ, Kaouk JH, Hegarty NJ, et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol 2008; 179: 1277-1281
17. Raman JD, Stern JM, Zeltser I, Kabbani W, Cadeddu JA,. Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging. J Urol 2008; 179: 2142-2145
18. Davenport MS, Caoili EM, Cohan RH, et al. MRI and CT characteristics of successfully ablated renal masses: imaging surveillance after radiofrequency ablation. AJR Am J Roentgenol 2009; 192: 1571-1578
19. Matin SF,. Determining failure after renal ablative therapy for renal cell carcinoma: false-negative and false-positive imaging findings. Urology 2010; 75: 1254-1257
20. Javadi S, Matin SF, Tamboli P, Ahrar K,. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Intervent Radiol 2007; 18: 1186-1191
21. Klingler HC, Marberger M, Mauermann J, Remzi M, Susani M,. 'Skipping' is still a problem with radiofrequency ablation of small renal tumours. BJU Int 2007; 99: 998-1001
22. Anderson JK, Baker M, Jaffers O, Pearle MS, Lindberg GL, Cadeddu JA,. Time course of nicotinamide adenine dinucleotide diaphorase staining after renal radiofrequency ablation influences viability assessment. J Endourol 2007; 21: 223-227
23. Hsu TH, Fidler ME, Gill IS,. Radiofrequency ablation of the kidney: acute and chronic histology in porcine model. Urology 2000; 56: 872-875